Novartis AG - H5820Q150
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | History | Reduced | 28,214 | 4,267 | 0.16% | 0.16% | 1 | -3,110 | -9.93% | Q1 2026 | May 12, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | History | Reduced | 17,057 | 2,579 | 0.14% | 0.18% | 2 | -996 | -5.52% | Q1 2026 | Apr 15, 2026 |